Yoshimura, Yuta
Hamaguchi, Masahide
Hashimoto, Yoshitaka
Okamura, Takuro
Nakanishi, Naoko
Obora, Akihiro
Kojima, Takao
Fukui, Michiaki
Article History
Received: 30 April 2021
Accepted: 30 July 2021
First Online: 9 August 2021
Declarations
:
: Informed consent was obtained in the form of opt-out on the web-site (ExternalRef removed). Subjects who were unwilling to participate were excluded from the study. The ethics committee of Asahi University Hospital approved the study (ID: 2018-09-01). The study was conducted according to the principles of the Declaration of Helsinki.
: Not applicable.
: Dr. Hamaguchi received grants from Mitsubishi Tanabe Pharma Corp., Astellas Pharma Inc., Sanofi K.K., Asahi Kasei Pharma, Nippon Boehringer Ingelheim Co. Ltd., Daiichi Sankyo Co. Ltd., Takeda Pharma Co. Ltd, Sumitomo Dainippon Pharma Co. Ltd., Kyowa Kirin Co. Ltd., Novo Nordisk Pharma Ltd., and Eli Lilly Japan K.K., outside the submitted work. Dr. Hashimoto reports personal fees from Mitsubishi Tanabe Pharma Corp., Daiichi Sankyo Co. Ltd., Sanofi K.K., and Novo Nordisk Pharma Ltd. outside the submitted work. Dr. Fukui received grants from Mitsubishi Tanabe Pharma Corp, Sanwa Kagagu Kenkyusho CO., LtD., Kowa Pharma Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Daiichi Sankyo Co. Ltd., Takeda Pharma Co. Ltd., Astellas Pharma Inc., Sanofi K.K., Kissei Phama Co. Ltd., MSD K.K., Kyowa Kirin Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Novo Nordisk Pharma Ltd., Ono Pharma Co. Ltd., Eli Lilly Japan K.K., Taisho Pharma Co., Ltd., Tejin Pharma LtD., Nippon Chemiphar Co., Ltd., Johnson & Johnson k.k. Medical Co., Abbott japan Co. Ltd., and Terumo Corp., and received honoraria from Novo Nordisk Pharma Ltd., Mitsubishi Tanabe Pharma Corp., Teijin Pharma Ltd., Sanofi K.K., Takeda Pharma Co. Ltd., Astellas Pharma Inc., MSD K.K., Arkray Inc., Kissei Pharma Co., Ltd., Kyowa Kirin Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Daiichi Sankyo Co. Ltd., Kowa Pharma Co. Ltd., Ono Pharma Co. Ltd., Abbott japan Co. Ltd., Eli Lilly Japan K.K., Medtronic Japan Co. Ltd., Sanwa Kagaku Kenkyusho Co. Ltd., Nippon Boehringer Ingelheim Co., Ltd., Taisho Pharma Co., Ltd., Bayer Yakuhin, Ltd., AstraZeneca K.K., Mochida Pharma Co. Ltd., and Nipro Corp. outside the submitted work. The sponsors were not involved in the study design; data collection, analysis, and interpretation; writing of this manuscript; or the decision to submit the article for publication. The authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article. The authors declare that, although they are affiliated with a department that is supported financially by a pharmaceutical company, they received no funding for this study, which does not alter their adherence to all the journal policies on sharing data and materials. The other authors have nothing to disclose.